| Name | (R)-Pirtobrutinib |
|---|
| Description | (R)-Pirtobrutinib ((R)-LOXO-305) is a less active enantiomer of Pirtobrutinib. Pirtobrutinib (LOXO-305), a highly selective and non-covalent next generation BTK inhibitor, inhibits diverse BTK C481 substitution mutations[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C22H21F4N5O3 |
|---|---|
| Molecular Weight | 479.43 |